Stock Market

Ocugen (NASDAQ:OCGN) stock has surged by over 2,600% in the last year. This rally is not surprising, since Ocugen and Bharat Biotech have signed a deal to co-develop a novel-coronavirus vaccine candidate, Covaxin. However, it’s also worth noting that OCGN stock is well below its recent high of $18.80. Source: Shutterstock After a deep correction,

The meme stock phenomenon seemed like it was over and done with. But, as seen from the latest movement from GameStop (NYSE:GME) stock, it’s not over just yet. Looking to beat the so-called “smart money” at their own game once again, retail investors, such as those active on Reddit’s r/WallStreetBets subreddit, are back in the

As most people spent the majority of 2020 stuck at home, many realized that they wanted to spruce up their surroundings. If they were going to spend so much time at home, why not take some of that extra free time from not commuting and add some upgrades into their homes. This created a strong

If you want to speculate on Light Detection and Ranging (LiDAR), a technology for making cars autonomous or at least safer, the place to be has been MicroVision (NASDAQ:MVIS). Source: temp-64GTX/Shutterstock.com This doesn’t mean MicroVision has what will be the standard solution. But it’s certainly where the action is, the volatility and the wild price

United Airlines (NASDAQ:UAL) stock has had a pretty good year so far. As of May 27, UAL stock is up over 36.7% year-to-date (YTD). It’s also up 100% over the past year. This is despite the heavy dilution from a number of equity capital raises in the last 12 months. Source: travelview / Shutterstock.com I suspect

Over the past decade, marijuana has enjoyed a huge turnaround. The drug used to be illegal almost everywhere, but now, it’s widely available in much of North America. Investors have understandably piled into cannabis stocks to ride the boom. Is another such societal transformation under way? Source: Shutterstock Last November, Oregon legalized psychedelic mushrooms. That

Investors looking for a high-risk, high-reward investment in a vaccine maker should consider buying a small amount of Vaxart (NASDAQ:VXRT) stock. Source: Ascannio / Shutterstock.com Vaxart has developed a vaccine candidate for the coronavirus unique from its shot-reliant competitors in the form of a pill. The results of a Phase 1 trial of the pill

It’s the internet browser that changed everything but will be quietly put out to pasture. On June 15, 2022, Microsoft (NASDAQ:MSFT) will finally retire Internet Explorer. As I see it, this is a net win for people who own MSFT stock. Source: NYCStock / Shutterstock.com In fact, a celebration might be in order. As the browser

There has been a growing apprehension about entities listed through special purpose acquisition companies. The Securities and Exchange Commission has already been scrutinizing “misleading earnings projections” made by SPAC sponsors. On a relative basis, investor frenzy for SPACs might have declined. However, SPAC business combinations do provide exposure to some quality businesses. Paysafe (NYSE:PSFE) stock

Much of the time, I suspect, analysts who give a bearish take on a particular company do so because they have some level of disdain for it, no matter how minor. But that’s not the case with Novavax (NASDAQ:NVAX). After an initial hesitation for the investment narrative around NVAX stock, I’ve supported its bullish thesis.

Throughout the last year after its initial public offering, Rocket Companies (NYSE:RKT) stock trended in the $20 – $21.50 range. RKT stock peaking on March 2 is an exception. Shares reached $41.10, albeit for less than a day, after the company issued a special dividend. Source: Lori Butcher / Shutterstock.com The announcement squeezed short sellers,

Mortgage originator Rocket Companies (NYSE:RKT) has seen its shares decline in the middle of an otherwise red-hot housing market. The valuation on RKT stock, down more than 24% in the last three weeks, has now actually become quite reasonable. However… Source: Lori Butcher / Shutterstock.com Existing home sales fell 2.7% in April to a yearly

This is the first time I’m writing about Clover Health Investments (NASDAQ:CLOV). And one of the first things that came up in my research was a Hindenburg Research report that explains some, but not all, of the decline in CLOV stock. Source: Shutterstock However, since this is the first time I’m looking at the company, I’m going to put that

With its share price stuck below $1 and no compelling long-term business case, SNDL stock investors should steer clear of Canadians cannabis producer Sundial Growers (NASDAQ:SNDL). Source: Jetacom Autofocus / Shutterstock.com A Penny Stock Fantasy Investors continuing to hold out hope that SNDL stock will again surge as high as $4 per share, as it

Workhorse (NASDAQ:WKHS) has spent a lot of time in the headlines over the past year. At first, investors were thrilled. Being among the finalists for a massive U.S. Postal Service (USPS) contract lit the EV maker’s stock on fire. From February 2020 to February 2021, WKHS posted a phenomenal 1,260% gain. However, that rapid growth was

Since the start of May, tech stocks, including many so called “Reddit stocks,” have trended lower. The cause? Namely, fears of rising inflation. Related to this has been worries the Federal Reserve will do a 180 on its near-zero interest-rate policy. On top of this, other factors have contributed to increased uncertainty. Some have speculated

Oatly (NASDAQ:OTLY), the Swedish producer of oat milk, was a hit at its May 20 initial public offering (IPO). OTLY stock was priced at $17 but had its first public trade at $22.12. It then fell during the day to finish at $20.20. The shares came roaring back overnight, opening at $22.20. Source: Katrinshine /

I incorporated Nano Dimension (NASDAQ:NNDM) as part of my speculation portfolio. So far, this wager has not panned out very well. Therefore, you may want to take my take of NNDM stock with a huge grain of salt. Source: Spyro the Dragon / Shutterstock.com Nevertheless, I’m still going to stay the course with Nano Dimension.

MindMed (NASDAQ:MNMD) stock may be up over 665% over the past twelve months. But, is this psychedelics play on the verge of taking off once again? Source: Shutterstock As InvestorPlace’s William White reported May 17, the company has made big progress with the Food and Drug Administration (FDA), regarding one of its key initiatives, Project

Now that the merger with Aphria has passed, does it make sense to purchase Tilray (NASDAQ:TLRY) stock? That’s the basic question for which investors are seeking an answer.  Source: Jarretera / Shutterstock.com For investors who want to establish a position in Tilray now, they’ll be making a bet that its U.S. consumer packaged goods (CPG)